[1] Han JM, Kim WG, Kim TY,et al. Effects of low-dose and high-dose postoperative radioiodine therapy on the clinical outcome in patients with small differentiated thyroid cancer having microscopic extrathyroidal extension[J].Thyroid,2014,24(5):820-825. [2] 李晨,田文,臧宇,等.喉返神经解剖病理变异对甲状腺癌术中规范化神经监测的影响[J].海南医学,2016,27(3):392-394. [3] Wei Q, Tianbo J, Qi Y, et al.PRIMA-1 Selectively Induces Global DNA Demethylation in p53 Mutant-Type Thyroid Cancer Cells[J].J Biomed Nanotechnol,2014,10(7):1249-1258. [4] 张楠,邱新光.PET/CT 对分化型甲状腺癌术后复发的诊断价值[J].中华内分泌外科杂志,2015,17(2):136-139. [5] 王桂兴.青年甲状腺癌的临床病理特点及复发因素分析[J].中国现代普通外科进展,2016,19(10):769-772. [6] 周爱军,王洪勇,李振,等.甲状腺癌组织中BRMSI和Cx43的表达与患者临床病理及预后的关系[J].中国普通外科杂志,2017,26(2):259-264. [7] 唐小乔,张寅,桑剑锋,等.甲状腺微小乳头状癌中央区淋巴结转移的临床特点及清扫价值[J].局解手术学杂志,2016,(1):38-41. [8] 郑绪才,王圣应,刘松,等.老年甲状腺癌术后复发的危险因素[J].中国老年学杂志,2016,36(2):367-368. [9] 李娇,林岩松.不同复发风险分层分化型甲状腺癌的131I治疗获益[J].中华核医学与分子影像杂志,2017,37(8):506-510. [10] Ortega-Porcayo LA, Leal-Lopez A, Soriano-Lopez ME, et al.Assessment of paraspinal muscle atrophy percentage after minimally invasive transforaminal lumbar interbody fusion and unilateral instrumentation using a novel contralateral intact muscle-controlled model[J].Asian Spine J,2018,12(2):256-262.